(Q33590557)

English

Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201). (English)

1 reference

Europe PubMed Central

28 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

papillary carcinoma

1 reference

based on heuristic

inferred from title

Francesca Casagrande

object named as

Francesca Casagrande

4

0 references

author name string

Karim El-Sahwi

1

1 reference

Europe PubMed Central

28 July 2017

Stefania Bellone

2

1 reference

Europe PubMed Central

28 July 2017

Emiliano Cocco

3

1 reference

Europe PubMed Central

28 July 2017

Marta Bellone

5

1 reference

Europe PubMed Central

28 July 2017

Maysa Abu-Khalaf

6

1 reference

Europe PubMed Central

28 July 2017

Natalia Buza

7

1 reference

Europe PubMed Central

28 July 2017

Fattaneh A Tavassoli

8

1 reference

Europe PubMed Central

28 July 2017

Pei Hui

9

1 reference

Europe PubMed Central

28 July 2017

Dominik Rüttinger

10

1 reference

Europe PubMed Central

28 July 2017

Dan-Arin Silasi

11

1 reference

Europe PubMed Central

28 July 2017

Masoud Azodi

12

1 reference

Europe PubMed Central

28 July 2017

Peter E Schwartz

13

1 reference

Europe PubMed Central

28 July 2017

Thomas J Rutherford

14

1 reference

Europe PubMed Central

28 July 2017

Sergio Pecorelli

15

1 reference

Europe PubMed Central

28 July 2017

Alessandro D Santin

16

1 reference

Europe PubMed Central

28 July 2017

publication date

6 January 2010

1 reference

Europe PubMed Central

28 July 2017

Molecular Cancer Therapeutics

1 reference

Europe PubMed Central

28 July 2017

9

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

57-66

1 reference

Europe PubMed Central

28 July 2017

Nuclear signalling by tumour-associated antigen EpCAM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Clear-cell and papillary serous cancer: treatment options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

The biology of the 17-1A antigen (Ep-CAM)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Endometrial papillary serous carcinoma: patterns of spread and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Two pathogenetic types of endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Natural killer cells in human solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

The regulation of complement on cell surfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

21 June 2018

Drug evaluation: adecatumumab, an engineered human anti-EpCAM antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

Natural killer cell activity of prostatic cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2806489

31 October 2018

In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ep-CAM overexpression in breast cancer as a predictor of survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20053761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1535-7163.MCT-09-0675

1 reference

Europe PubMed Central

28 July 2017

release_lqibiphh7neqppsce66qixl4a4

1 reference

https://api.fatcat.wiki/v0/release/lqibiphh7neqppsce66qixl4a4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33590557&oldid=1843761160"